[arista]

[An experimental drug for severe Covid
cuts the risk of hospitalisation or death
by about half, interim clinical trial results suggest.

The tablet - molnupiravir - was given
twice a day to patients recently
diagnosed with the disease.

US drug-maker Merck said its results
were so positive that outside monitors
had asked to stop the trial early.

It said it would apply for emergency
use authorisation for the drug
in the US in the next two weeks.]


https://www.bbc.co.uk/news/health-58764440


Lets hope it gets to the UK soon.


[COVID-19: UK shows interest in antiviral pill molnupiravir
after trial shows it could halve hospitalisations and deaths]


https://news.sky.com/story/covid-19-...eaths-12423286